Literature DB >> 18365209

Infectious intracranial aneurysms in the pediatric population: endovascular treatment with Onyx.

Christopher S Eddleman1, Daniel Surdell, Arthur DiPatri, Tadanori Tomita, Ali Shaibani.   

Abstract

OBJECTS: Infectious intracranial aneurysms present a treatment challenge in the pediatric population. Current endovascular strategies and tools have been developed, which make treatment of infectious intracranial aneurysms with liquid embolics safe and effective. This study reviews the use of the liquid embolic Onyx in the treatment of infectious intracranial aneurysms in the pediatric population.
MATERIALS AND METHODS: We used an endovascular approach to treat ruptured infectious intracranial aneurysms. We embolized the aneurysms with either Onyx alone or in combination with platinum coils.
CONCLUSION: Endovascular therapy with liquid embolics (Onyx) has been shown to be a safe and effectual treatment option in the case of pediatric infectious intracranial aneurysms. The combination of endovascular modalities can also be used to tailor the therapeutic goal of exclusion of infectious aneurysms with good results. Further studies are needed to assess the long-term effectiveness of this approach to pediatric infectious intracranial aneurysms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18365209     DOI: 10.1007/s00381-008-0614-8

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  22 in total

1.  Endovascular treatment of bacterial intracranial aneurysms.

Authors:  G Scotti; M H Li; C Righi; F Simionato; A Rocca
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

2.  Different modalities of treatment of intracranial mycotic aneurysms: Report of 4 cases.

Authors:  Ichiro Nakahara; Mahmoud M Taha; Toshio Higashi; Yasushi Iwamuro; Mitsutoshi Iwaasa; Yoshihiko Watanabe; Kenzo Tsunetoshi; Toshihiro Munemitsu
Journal:  Surg Neurol       Date:  2006-07-21

3.  Pathogenesis of cerebral mycotic aneurysms.

Authors:  G F Molinari; L Smith; M N Goldstein; R Satran
Journal:  Neurology       Date:  1973-04       Impact factor: 9.910

4.  Endovascular treatment of ruptured, peripheral cerebral aneurysms: parent artery occlusion with short Guglielmi detachable coils.

Authors:  H J Cloft; D F Kallmes; M E Jensen; G Lanzino; J E Dion
Journal:  AJNR Am J Neuroradiol       Date:  1999-02       Impact factor: 3.825

Review 5.  Intracranial aneurysms in children aged under 15 years: review of 59 consecutive children with 75 aneurysms.

Authors:  Pierre Lasjaunias; Siddharta Wuppalapati; Hortensia Alvarez; Georges Rodesch; Augustin Ozanne
Journal:  Childs Nerv Syst       Date:  2005-04-15       Impact factor: 1.475

6.  Endovascular approach for an intracranial mycotic aneurysm associated with infective endocarditis.

Authors:  J Utoh; Y Miyauchi; H Goto; H Obayashi; T Hirata
Journal:  J Thorac Cardiovasc Surg       Date:  1995-08       Impact factor: 5.209

7.  Management of intracranial infectious aneurysms: a series of 16 cases.

Authors:  Loi K Phuong; Michael Link; Eelco Wijdicks
Journal:  Neurosurgery       Date:  2002-11       Impact factor: 4.654

8.  Current multimodality management of infectious intracranial aneurysms.

Authors:  J Y Chun; W Smith; V V Halbach; R T Higashida; C B Wilson; M T Lawton
Journal:  Neurosurgery       Date:  2001-06       Impact factor: 4.654

9.  Endovascular treatment for a unusually large mycotic aneurysm manifesting as intracerebral hemorrhage - case report.

Authors:  Yoshie Hara; Kohkichi Hosoda; Taro Wada; Hidehito Kimura; Eiji Kohmura
Journal:  Neurol Med Chir (Tokyo)       Date:  2006-11       Impact factor: 1.742

10.  Endovascular treatment of intracranial arterio-venous malformations with Onyx embolization: preliminary experience.

Authors:  Francesco Florio; Walter Lauriola; Michele Nardella; Vincenzo Strizzi; Stefano Vallone; Marco Pastore Trossello
Journal:  Radiol Med       Date:  2003 Nov-Dec       Impact factor: 3.469

View more
  8 in total

Review 1.  Off-label use of drugs and devices in the neuroendovascular suite.

Authors:  M M Abdihalim; A E Hassan; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-21       Impact factor: 3.825

2.  Rupture of cerebral myxomatous aneurysm months after resection of the primary cardiac tumor.

Authors:  Christopher S Eddleman; Numa R Gottardi-Littell; Bernard R Bendok; H Hunt Batjer; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

Review 3.  Endovascular treatment of infectious intracranial aneurysms.

Authors:  Bradley A Gross; Ajit S Puri
Journal:  Neurosurg Rev       Date:  2012-08-15       Impact factor: 3.042

Review 4.  Management of infectious intracranial aneurysms in the pediatric population.

Authors:  Bruno C Flores; Ankur R Patel; Bruno P Braga; Bradley E Weprin; H Hunt Batjer
Journal:  Childs Nerv Syst       Date:  2016-05-14       Impact factor: 1.475

5.  The use of Onyx for embolization of central nervous system arteriovenous lesions in pediatric patients.

Authors:  R Thiex; A Williams; E Smith; R M Scott; D B Orbach
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-12       Impact factor: 3.825

6.  Diagnosis and management of mycotic aneurysms.

Authors:  Luis R León; Joseph L Mills
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

7.  Successful flow diversion treatment of ruptured infectious middle cerebral artery aneurysms with the use of Pipeline Flex with Shield technology.

Authors:  Derek C Samples; Vijay M Ravindra; Dewey J Thoms; Izabela Tarasiewicz; Ramesh Grandhi
Journal:  Interv Neuroradiol       Date:  2021-01-28       Impact factor: 1.610

Review 8.  Endovascular treatment of cerebral mycotic aneurysm: a review of the literature and single center experience.

Authors:  Mario Zanaty; Nohra Chalouhi; Robert M Starke; Stavropoula Tjoumakaris; L Fernando Gonzalez; David Hasan; Robert Rosenwasser; Pascal Jabbour
Journal:  Biomed Res Int       Date:  2013-12-09       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.